Posted in | Nanobusiness

CombiMatrix Ranked 156 on Deloitte's 2008 Technology Fast 500 in North America

CombiMatrix Corporation (Nasdaq:CBMX), a diversified biotechnology business, through the development of proprietary technologies, products and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology research, defense and homeland security markets, today announced that it ranked number 156 on Deloitte's 2008 Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications and life sciences companies in North America. Rankings are based on percentage of fiscal year revenue growth over five years, from 2003-2007.

Overall, companies that ranked on the 2008 Technology Fast 500 had growth rates ranging from 242 to 138,762 percent over five years, with an average growth rate of 3,043 percent.

CombiMatrix's President and CEO, Dr. Amit Kumar, credits a tremendously talented and passionate team with the company's revenue growth from 2003-2007. Dr. Kumar said, "We are pleased to be recognized by Deloitte & Touche for our growth. This recognition is a testament to the hard work, talent and perseverance of our employees. Our company is committed to the delivery of sophisticated genetic tests for ill patients. We are doing this now and hope to expand into the future and with additional life-saving products."

In addition to ranking on Deloitte's Technology Fast 500, CombiMatrix ranked 12th on the Washington Technology Fast 50, which is a ranking of the 50 fastest growing technology firms in Washington State.

"Deloitte's Technology Fast 500 recognizes companies who have achieved extraordinary growth in North America's most innovative and competitive market sectors," said Phil Asmundson, Deloitte LLP vice chairman and national managing partner for Technology, Media and Telecommunications. "We congratulate CombiMatrix on this significant accomplishment."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback